Suchergebnisse - "Daratumumab"

PubPharm (248)

91

Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada

enthalten in: European journal of haematology | 2021

von Reece, D. | Masih-Khan, E. | Atenafu, E. | +14

92

Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma

enthalten in: International journal of molecular sciences | 2021

von Nakamura, A. | Suzuki, S. | Kanasugi, J. | +5

93

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma

enthalten in: British journal of haematology | 2021

von Avivi, I. | Balaban, R. | Shragai, T. | +14

94

Not only a time-saving approach : Is it the time of subcutaneous formulation for daratumumab administration?

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2021

von Perego, G. | Longobardo, G. | Veneziano, C. | +2

95

Venous thromboembolism in patients with multiple myeloma receiving daratumumab-based regimens : a post hoc analysis of phase 3 clinical trials

enthalten in: Leukemia & lymphoma | 2021

von Wang, J. | Park, C. | Arroyo-Suarez, R.

96

Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Lee, S. | Sung, P. | Park, S. | +5

97

Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence

enthalten in: Cancer science | 2021

von Kitadate, A. | Terao, T. | Narita, K. | +7

98

Phase I study protocol : NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

enthalten in: Future oncology (London, England) | 2021

von Shah, N. | Perales, M. | Turtle, C. | +11

99

Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma : results of the phase III study CANDOR by prior lines of therapy

enthalten in: British journal of haematology | 2021

von Quach, H. | Nooka, A. | Samoylova, O. | +12

100

Efficacy and safety of daratumumab in the treatment of multiple myeloma : a systematic review and meta-analysis

enthalten in: The Journal of international medical research | 2021

von Wang, Y. | Li, Y. | Chai, Y.